Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin?
ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of thrombosis and/or obstetric events, and persistent high titers of circulating antiphospholipid antibodies (aPL). Most patients display both clinical signs, although some patients can have isolated vas...
- Autores:
-
Cadavid Jaramillo, Ángela Patricia
- Tipo de recurso:
- http://purl.org/coar/resource_type/c_5794
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/31532
- Acceso en línea:
- https://hdl.handle.net/10495/31532
- Palabra clave:
- Síndrome Antifosfolípido
Antiphospholipid Syndrome
Anticuerpos Antifosfolípidos
Antibodies, Antiphospholipid
Trombosis de la Vena
Venous Thrombosis
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-sa/2.5/co/
| id |
UDEA2_6e453520bd740b11d855e1ec4eeae7b6 |
|---|---|
| oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/31532 |
| network_acronym_str |
UDEA2 |
| network_name_str |
Repositorio UdeA |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| title |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| spellingShingle |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? Síndrome Antifosfolípido Antiphospholipid Syndrome Anticuerpos Antifosfolípidos Antibodies, Antiphospholipid Trombosis de la Vena Venous Thrombosis |
| title_short |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| title_full |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| title_fullStr |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| title_full_unstemmed |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| title_sort |
Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin? |
| dc.creator.fl_str_mv |
Cadavid Jaramillo, Ángela Patricia |
| dc.contributor.author.none.fl_str_mv |
Cadavid Jaramillo, Ángela Patricia |
| dc.contributor.conferencename.spa.fl_str_mv |
Latin American and Caribbean Congress of Immunology ALACI 2022 (13 : 7 de junio de 2022 : Varadero, Matanzas, Cuba) |
| dc.contributor.researchgroup.spa.fl_str_mv |
Grupo de Investigación en Trombosis Grupo Reproducción |
| dc.subject.decs.none.fl_str_mv |
Síndrome Antifosfolípido Antiphospholipid Syndrome Anticuerpos Antifosfolípidos Antibodies, Antiphospholipid Trombosis de la Vena Venous Thrombosis |
| topic |
Síndrome Antifosfolípido Antiphospholipid Syndrome Anticuerpos Antifosfolípidos Antibodies, Antiphospholipid Trombosis de la Vena Venous Thrombosis |
| description |
ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of thrombosis and/or obstetric events, and persistent high titers of circulating antiphospholipid antibodies (aPL). Most patients display both clinical signs, although some patients can have isolated vascular or obstetric variants. aPL are a heterogeneous group of autoantibodies directed against negatively charged phospholipids or phospholipid-binding proteins. It seems that the same aPL are present in the two clinical manifestations of APS, but it is evident that vascular APS and obstetric APS have different pathogenic mechanisms, the first being caused by a state of hypercoagulability and the second by an inflammatory phenomenon. It is not yet clear if there are different specificities of these aPL. Sera or polyclonal IgG from women with several clinical manifestations of APS show differential effects on various cellular models in in vitro assays. On trophoblast cells there is a decrease of trophoblast invasion. On endothelial cells these aPL stimulated nitrotyrosine expression, reduction in eNOS phosphorylation at Ser1177, mitochondrial hyperpolarization and activation of autophagic pathways, expression of adhesion molecules and the generation of procoagulant microparticles. In conclusion, whether vascular APS and obstetric APS are two sides of the same coin, or two different coins altogether, has not yet been clarified. It would be very useful both for the diagnosis and for the therapeutic approach of the patients to define whether the determining factors of each variant of the disease are the aPL per se or whether there are other factors that influence the onset and pathogenesis of obstetric or vascular APS. |
| publishDate |
2022 |
| dc.date.accessioned.none.fl_str_mv |
2022-10-28T13:55:33Z |
| dc.date.available.none.fl_str_mv |
2022-10-28T13:55:33Z |
| dc.date.issued.none.fl_str_mv |
2022-06-07 |
| dc.type.spa.fl_str_mv |
Documento de conferencia |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_c94f |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_5794 |
| dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/EC |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_b1a7d7d4d402bcce |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/draft |
| format |
http://purl.org/coar/resource_type/c_5794 |
| status_str |
draft |
| dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/10495/31532 |
| url |
https://hdl.handle.net/10495/31532 |
| dc.language.iso.spa.fl_str_mv |
eng |
| language |
eng |
| dc.relation.conferencedate.spa.fl_str_mv |
2022-06-06/2022-06-10 |
| dc.relation.conferenceplace.spa.fl_str_mv |
Meliá Internacional Varadero, Varadero, Matanzas, Cuba |
| dc.relation.ispartofjournal.spa.fl_str_mv |
ALACI22 - 13th Latin American and Caribbean Immunology and 7th Cuban Immunology Society Congresses |
| dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-sa/2.5/co/ |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.accessrights.*.fl_str_mv |
Atribución-NoComercial-CompartirIgual 2.5 Colombia |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/2.5/co/ https://creativecommons.org/licenses/by-nc-sa/4.0/ Atribución-NoComercial-CompartirIgual 2.5 Colombia http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.place.spa.fl_str_mv |
Varadero, Cuba |
| institution |
Universidad de Antioquia |
| bitstream.url.fl_str_mv |
https://bibliotecadigital.udea.edu.co/bitstreams/15ef9690-7224-4d56-83ad-5347201401c2/download https://bibliotecadigital.udea.edu.co/bitstreams/95712c32-1005-4056-b398-758eb2c79dd7/download https://bibliotecadigital.udea.edu.co/bitstreams/c4f1b908-c31d-426c-ab39-f8fc4a47fb7b/download https://bibliotecadigital.udea.edu.co/bitstreams/7c1891d1-b412-4a66-884a-52228130ae52/download https://bibliotecadigital.udea.edu.co/bitstreams/b4edc211-7e5b-41ae-9a2c-0f994bf17b38/download https://bibliotecadigital.udea.edu.co/bitstreams/aed593f7-ff35-4a7f-aa2c-1fbc366034dd/download https://bibliotecadigital.udea.edu.co/bitstreams/dda5c2bc-22a6-4bbb-97ec-241a35142273/download |
| bitstream.checksum.fl_str_mv |
5a8966724dae55d93edb76c06925e6eb 724f7c880d0e03251b840df235a43470 e2060682c9c70d4d30c83c51448f4eed 8a4605be74aa9ea9d79846c1fba20a33 13744842deebd78363d5d909c64c2e45 998b5eca375eaf15e07939e21e0511d0 8ffc7c9c80e26bec9130fa82d85e3309 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositorio Institucional de la Universidad de Antioquia |
| repository.mail.fl_str_mv |
aplicacionbibliotecadigitalbiblioteca@udea.edu.co |
| _version_ |
1851052550008078336 |
| spelling |
Cadavid Jaramillo, Ángela PatriciaLatin American and Caribbean Congress of Immunology ALACI 2022 (13 : 7 de junio de 2022 : Varadero, Matanzas, Cuba)Grupo de Investigación en TrombosisGrupo Reproducción2022-10-28T13:55:33Z2022-10-28T13:55:33Z2022-06-07https://hdl.handle.net/10495/31532ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of thrombosis and/or obstetric events, and persistent high titers of circulating antiphospholipid antibodies (aPL). Most patients display both clinical signs, although some patients can have isolated vascular or obstetric variants. aPL are a heterogeneous group of autoantibodies directed against negatively charged phospholipids or phospholipid-binding proteins. It seems that the same aPL are present in the two clinical manifestations of APS, but it is evident that vascular APS and obstetric APS have different pathogenic mechanisms, the first being caused by a state of hypercoagulability and the second by an inflammatory phenomenon. It is not yet clear if there are different specificities of these aPL. Sera or polyclonal IgG from women with several clinical manifestations of APS show differential effects on various cellular models in in vitro assays. On trophoblast cells there is a decrease of trophoblast invasion. On endothelial cells these aPL stimulated nitrotyrosine expression, reduction in eNOS phosphorylation at Ser1177, mitochondrial hyperpolarization and activation of autophagic pathways, expression of adhesion molecules and the generation of procoagulant microparticles. In conclusion, whether vascular APS and obstetric APS are two sides of the same coin, or two different coins altogether, has not yet been clarified. It would be very useful both for the diagnosis and for the therapeutic approach of the patients to define whether the determining factors of each variant of the disease are the aPL per se or whether there are other factors that influence the onset and pathogenesis of obstetric or vascular APS.Universidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODIColombia. Ministerio de Ciencia Tecnología e Innovación - MinicienciasCOL0010421COL0007631application/pdfenghttp://creativecommons.org/licenses/by-nc-sa/2.5/co/https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccessAtribución-NoComercial-CompartirIgual 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2Obstetric and vascular antiphospholipid syndrome: Two sides of the same coin?Documento de conferenciahttp://purl.org/coar/resource_type/c_5794http://purl.org/coar/resource_type/c_c94fhttps://purl.org/redcol/resource_type/EChttp://purl.org/coar/version/c_b1a7d7d4d402bcceinfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/draftVaradero, CubaSíndrome AntifosfolípidoAntiphospholipid SyndromeAnticuerpos AntifosfolípidosAntibodies, AntiphospholipidTrombosis de la VenaVenous Thrombosis2022-06-06/2022-06-10Meliá Internacional Varadero, Varadero, Matanzas, CubaALACI22 - 13th Latin American and Caribbean Immunology and 7th Cuban Immunology Society Congressesgrid.412881.6grid.433658.fMecanismos de daño y disfunción endotelial en el síndrome antifosfolípido: ¿hay diferencias de acuerdo a las manifestaciones clínicas del síndrome?”2015-7448 y 111580762949; 111571249846PublicationORIGINALAPS_conference_A_Cadavid_final-pdf.pptxAPS_conference_A_Cadavid_final-pdf.pptxPresentaciónapplication/vnd.openxmlformats-officedocument.presentationml.presentation47520744https://bibliotecadigital.udea.edu.co/bitstreams/15ef9690-7224-4d56-83ad-5347201401c2/download5a8966724dae55d93edb76c06925e6ebMD51trueAnonymousREADAbstract-Antiphospholipid_antibodies-A.Cadavid.pdfAbstract-Antiphospholipid_antibodies-A.Cadavid.pdfResumenapplication/pdf11257https://bibliotecadigital.udea.edu.co/bitstreams/95712c32-1005-4056-b398-758eb2c79dd7/download724f7c880d0e03251b840df235a43470MD52falseAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-81051https://bibliotecadigital.udea.edu.co/bitstreams/c4f1b908-c31d-426c-ab39-f8fc4a47fb7b/downloade2060682c9c70d4d30c83c51448f4eedMD53falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/7c1891d1-b412-4a66-884a-52228130ae52/download8a4605be74aa9ea9d79846c1fba20a33MD54falseAnonymousREADTEXTAPS_conference_A_Cadavid_final-pdf.pptx.txtAPS_conference_A_Cadavid_final-pdf.pptx.txtExtracted texttext/plain7069https://bibliotecadigital.udea.edu.co/bitstreams/b4edc211-7e5b-41ae-9a2c-0f994bf17b38/download13744842deebd78363d5d909c64c2e45MD55falseAnonymousREADAbstract-Antiphospholipid_antibodies-A.Cadavid.pdf.txtAbstract-Antiphospholipid_antibodies-A.Cadavid.pdf.txtExtracted texttext/plain2226https://bibliotecadigital.udea.edu.co/bitstreams/aed593f7-ff35-4a7f-aa2c-1fbc366034dd/download998b5eca375eaf15e07939e21e0511d0MD56falseAnonymousREADTHUMBNAILAbstract-Antiphospholipid_antibodies-A.Cadavid.pdf.jpgAbstract-Antiphospholipid_antibodies-A.Cadavid.pdf.jpgGenerated Thumbnailimage/jpeg13703https://bibliotecadigital.udea.edu.co/bitstreams/dda5c2bc-22a6-4bbb-97ec-241a35142273/download8ffc7c9c80e26bec9130fa82d85e3309MD57falseAnonymousREAD10495/31532oai:bibliotecadigital.udea.edu.co:10495/315322025-03-27 00:10:38.285http://creativecommons.org/licenses/by-nc-sa/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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 |
